Constitutive expression of functional 4-1BB (CD137) ligand on carcinoma cells1

Journal of Immunology

Volumn 165, Issue 5, 2000, Pages 2903-2910

  Salih, H R ^a   Kosowski, S G ^a   Haluska, V F ^a   Starling, G C ^a   Loo, D T ^a   Lee, F ^a   Aruffo, A A ^a   Trail, P A ^a   Kiener, P A ^a  

^a BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN; CD137 ANTIGEN; HYBRID PROTEIN; INTERLEUKIN 4; LIGAND; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ARTICLE; CARCINOMA CELL; CELL INTERACTION; CELL LINE; CONTROLLED STUDY; CYTOKINE RELEASE; HUMAN; HUMAN CELL; NORTHERN BLOTTING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL PROCESSING; SOLID TUMOR; T LYMPHOCYTE;

EID: 0034284196     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.165.5.2903     Document Type: Article

References (42)

1. The TNF receptor superfamily of cellular and viral proteins: Activation, costimulation, and death
2. Unraveling function in the TNF ligand and receptor families
3. A new superfamily of cell surface proteins related to the nerve growth factor receptor
4. Expression and structure of the human NGF receptor
5. Molecular cloning and expression of a receptor for human tumor necrosis factor
6. A receptor for tumor necrosis factor defines an unusual family of cellular and viral proteins
7. A B-lymphocyte activation molecule related to the nerve growth factor receptor and induced by cytokines in carcinomas
8. Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkin's disease
9. The T cell activation antigen CD27 is a member of the nerve growth factor/tumor necrosis factor receptor gene family
10. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis
11. cDNA sequences of two inducible T-cell genes
12. The biology of cachectin/TNF-α primary mediator of the host response
13. Molecular and biological characterization of a murine ligand for CD40
14. Molecular and biological characterization of a ligand for CD27 defines a new family of cytokines with homology to tumor necrosis factor
15. Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family
16. Molecular and biological characterization of human 4-1BB and its ligand
17. A p50 surface antigen restricted to human urinary bladder carcinomas and B lymphocytes
18. Melanoma cell expression of Fas (APO-1/CD95) ligand: Implications for tumor immune escape
19. Role of Fas ligand (CD95L) in immune escape: The tumor cell strikes back
20. Expression of Fas ligand in liver metastases of human colonic adenocarcinomas
21. Molecular cloning of a ligand for the inducible T cell gene 4-1BB: A member of an emerging family of cytokines with homology to tumor necrosis factor
22. Potential role of 4-1BB in T cell activation: Comparison with the costimulatory molecule CD28
23. - T lymphocytes by 4-1BB ligand
24. - T cells
25. Monoclonal antibodies against the 4-1BB T-cell activation molecule eradicate established tumors
26. + T cell proliferation and lead to the amplification in vivo of cytotoxic T cell responses
27. Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal
28. Role of 4-1BB ligand in costimulation of T lymphocyte growth and its up-regulation on M12 B lymphoma by cAMP
29. 4-1BB T cell antigen binds to mature B cells and macrophages and costimulates anti μ-primed splenic B cells
30. CD28-independent,TRAF2-dependent costimulation of resting T cells by 4-1BB ligand
31. CD137-induced apoptosis is independent of CD95
32. CD137 (ILA/4-1BB), a member of the TNF receptor family, induces monocyte activation via bi-directional signaling
33. Stimulation of tyrosine phosphorylation and calcium mobilization by Fcγ receptor cross-linking
34. Analysis of 4-1BBL and laminin binding to murine 4-1BB, a member of the tumor necrosis factor receptor superfamily, and comparison with human 4-1BB
35. Human B7-1 (CD80) and B7-2 (CD86) bind with similar avidities but distinct kinetics to CD28 and CTLA-4 receptors
36. Signals through 4-1BB are costimulatory to previously activated splenic T cells and inhibit activation-induced cell death
37. CD40 ligand-transduced costimulation of T cells in the development of helper function
38. Reverse signaling via CD30 ligand
39. Differential cytokine expression by human intestinal epithelial cell lines: Regulated expression of interleukin-8
40. Colonic epithelial cell lines as a source of interleukin-8: Stimulation by inflammatory cytokines and bacterial lipopolysaccharide
41. Amplification of tumor immunity by gene transfer of the co-stimulatory 4-1BB ligand: Synergy with the CD28 co-stimulatory pathway
42. 4-1BBL cooperates with B7-1 and B7-2 in converting a B cell lymphoma cell line into a long-lasting antitumor vaccine